2003
DOI: 10.1016/j.lfs.2003.06.004
|View full text |Cite
|
Sign up to set email alerts
|

Supplementation of L-arginine improves hypertension and lipid metabolism but not insulin resistance in diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0

Year Published

2005
2005
2018
2018

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 28 publications
(24 reference statements)
0
15
0
Order By: Relevance
“…Indeed, the increase of NO production has been reported in the retina of long lasting streptozotocin-induced diabetic rats [18]. As the synthesis of NO has been shown to be dependent on the availability of extracellular arginine [19][20][21], membrane transport of arginine may represent a rate-limiting step in local retina NO production, and thus in NO action.…”
Section: Discussionmentioning
confidence: 99%
“…Indeed, the increase of NO production has been reported in the retina of long lasting streptozotocin-induced diabetic rats [18]. As the synthesis of NO has been shown to be dependent on the availability of extracellular arginine [19][20][21], membrane transport of arginine may represent a rate-limiting step in local retina NO production, and thus in NO action.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, in streptozotocininduced diabetic rats, treatment with 2% arginine in their diet attenuated the elevated serum levels of triglyceride and LDL by about 20% [132]. Likewise, arginine treatment improved lipid metabolism in genetically diabetic and fatty rats [133]. Most recently, Fu et al [11] reported that a long-term arginine treatment reduced retroperitoneal fat mass by 45% and had no effect on the weight of other tissues in ZDF rats.…”
Section: Hypocholesterolemic Effect Of Nomentioning
confidence: 99%
“…These results agree with the previous reports from Dumont et al [11] who found that a low dose instead a high dose of L-arginine in drinking water significantly attenuates the development of hypertension in uraemic rats. Gouvêa et al [10] supported the hypothesis that in WK rats with renovascular hypertension L-arginine treatment (300 mg/day during 14 days) decreases the arterial pressure (23%) in the two-kidney, one-clip (2K1C) renovascular hypertension model induced hypertension rats, not only because of the already known vasodilator effects of NO formation, but also because there is an increase in renal excretion of water and sodium; Kawano et al [24] reported a significant reduction (11.3%) in systolic pressure in fed rats supplemented with 1.4% Larginine [24]. Nevertheless, Chang et al [12] reported that early in vitro studies using aorta or artery segments isolated from genetic and secondary hypertensive animals suggested that endothelium-dependent relaxation of blood vessels was impaired in hypertension.…”
Section: L-arginine Hypolipidemic Activitymentioning
confidence: 90%